B19.11

Clinical Causes: Viral infection with hepatitis B virus (HBV), transmitted through blood or bodily fluids Progression of chronic hepatitis B leading to liver failure Acute severe hepatitis B infection Complications arising from immunosuppression or co-infections Pre-existing liver disease that worsens illness severity

Key Symptoms: Altered mental state or consciousness, ranging from confusion to coma Jaundice, indicated by yellowing of skin and eyes Fatigue and weakness Abdominal pain or discomfort Nausea and vomiting Swelling in the abdomen due to fluid accumulation Dark urine and pale stool Bleeding tendency or bruising due to impaired blood clotting Fever or chills in some cases

Diagnosis Path: Diagnosing unspecified viral hepatitis B with hepatic coma involves a combination of clinical evaluation and laboratory tests. Key diagnostic steps include: - Blood tests to detect hepatitis B virus markers, liver enzymes, and signs of liver dysfunction - Imaging studies like ultrasound to assess liver size and detect complications - Assessment of mental status and neurological examination - Liver biopsy in some cases to determine the extent of liver damage The healthcare provider will analyze these results to confirm the presence of hepatitis B and the development of hepatic coma.

Treatment Protocols: Treating unspecified viral hepatitis B with hepatic coma typically involves urgent medical intervention aimed at stabilizing the patient and managing complications. Common approaches include: - Hospitalization in an intensive care unit for close monitoring - Administration of antiviral medications specific to hepatitis B to reduce viral replication - Supportive care such as IV fluids, oxygen, and nutritional support - Medications to reduce brain swelling and manage increased intracranial pressure - Measures to prevent bleeding and address coagulation issues - Treating underlying causes or concurrent infections - In severe cases, procedures like plasmapheresis or liver support systems may be considered Long-term management may involve ongoing antiviral therapy and regular monitoring to prevent relapse or progression.